阿哌沙班用于在非瓣膜性房颤患者预防中风及全身性栓塞

Apixaban is recommended as an option for preventing stroke and systemic embolism within its marketing authorisation, that is, in people with nonvalvular atrial fibrillation with 1 or more risk factors such as:

prior stroke or transient ischaemic attack

age 75 years or older

hypertension

diabetes mellitus

symptomatic heart failure.

学科代码：内科学 心血管病学 消化病学　　　关键词：阿哌沙班 非瓣膜性房颤患者 中风 全身性栓塞